The results showed that low S1 IgG responses were enriched in the group of <50, but not correlated with disease severity (Figure 4C), while high S1 IgG responses were enriched in mild COVID-19 patients in the group of >60 (Figure 4D). Here, PSMD1 is linked to COVID-19.